![Peter Greaney](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Greaney
Keine laufenden Positionen mehr
Karriereverlauf von Peter Greaney
Ehemalige bekannte Positionen von Peter Greaney
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CELGENE | Geschäftsführer | 01.01.2006 | 01.01.2018 |
ADC THERAPEUTICS SA | Corporate Officer/Principal | 01.09.2018 | - |
Ausbildung von Peter Greaney
University of East Anglia | Undergraduate Degree |
The University of Nottingham | Doctorate Degree |
Statistik
International
Vereinigtes Königreich | 3 |
Schweiz | 2 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 1 |
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ADC THERAPEUTICS SA | Health Technology |
Private Unternehmen | 1 |
---|---|
Celgene Corp.
![]() Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Börse
- Insiders
- Peter Greaney
- Erfahrung